Leap Therapeutics Inc (LPTX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Doug E. Onsi
Employees:
40
47 THORNDIKE STREET, SUITE B1-1, CAMBRIDGE, MA 02142
617 252 4343

Leap Therapeutics, Inc. acquires and develops therapies for the treatment of cancer. DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers.

Data derived from most recent annual or quarterly report
Market Cap 32.407 Million Shares Outstanding24.005 Million Avg 30-day Volume 164.418 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.5
Price to Revenue0.0 Debt to Equity0.0 EBITDA-87.169 Million
Price to Book Value0.5478 Operating Margin0.0 Enterprise Value-45.372 Million
Current Ratio7.982 EPS Growth-0.284 Quick Ratio7.772
1 Yr BETA -0.2543 52-week High/Low 6.95 / 0.27 Profit Margin0.0
Operating Cash Flow Growth-13.0461 Free Cash Flow to Firm (FCFF) TTM -60.84 Million Free Cash Flow to Equity (FCFE) TTM-60.633 Million
Altman Z-Score-5.086
Earnings Report2023-11-13
View SEC Filings from LPTX instead.

View recent insider trading info

Leap Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding LPTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LPTX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-08-25 by DIETZ THOMAS JOHN
  • 4: filed on 2023-08-25 by MARTIN PATRICIA A.
  • 4: filed on 2023-08-25 by RICHARD CHRISTIAN M
  • 4: filed on 2023-08-25 by SCHILSKY RICHARD
  • 4: filed on 2023-08-25 by GRANFIELD CHRISTINE
  • 4: filed on 2023-08-25 by O'MAHONY JOHN MARK
  • 4: filed on 2023-08-25 by BAUM JASON
  • 4: filed on 2023-08-25 by SIRARD CYNTHIA
  • 4: filed on 2023-04-04 by MIRABELLI CHRISTOPHER
  • 4: filed on 2023-04-04 by SIRARD CYNTHIA

    • Events (8k)

  • 8-K: filed on 2023-09-13:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-12:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-21:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
  • 8-K: filed on 2023-06-20:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-25:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-26:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-12:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    CAVANAUGH JAMES H

    • Director
    		 0 2023-08-23 2

    MIRABELLI CHRISTOPHER CHAIRMAN OF THE BOARD

    • Officer
    • Director
    		 0 2023-08-23 2

    LAWLOR AUGUSTINE CHIEF OPERATING OFFICER

    • Officer
    		 0 2023-08-23 2

    ONSI DOUGLAS E CEO,CFO,PRES.,GC,TREAS.,&SEC.

    • Officer
    • Director
    		 0 2023-08-23 3

    LI WILLIAM

    • Director
    		 0 2023-08-23 2

    LOSCALZO JOSEPH

    • Director
    		 0 2023-08-23 2

    MASHIACH NISSIM

    • Director
    		 0 2023-08-23 2

    DIETZ THOMAS JOHN

    • Director
    		 0 2023-08-23 2

    RICHARD CHRISTIAN M

    • Director
    		 0 2023-08-23 3

    SIRARD CYNTHIA CHIEF MEDICAL OFFICER

    • Officer
    		 0 2023-08-23 2

    O'MAHONY JOHN MARK CHIEF MANUFACTURING OFFICER

    • Officer
    		 0 2023-08-23 2

    GRANFIELD CHRISTINE VP, HEAD OF REG AFFAIRS/QUAL

    • Officer
    		 0 2023-08-23 2

    MARTIN PATRICIA A.

    • Director
    		 0 2023-08-23 3

    SCHILSKY RICHARD

    • Director
    		 0 2023-08-23 2

    BAUM JASON CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2023-08-23 2

    BERTAGNOLLI MONICA

    • Director
    		 55,000 2022-01-31 0

    PERCEPTIVE ADVISORS LLC

    PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

    EDELMAN JOSEPH

    • 10% Owner
    		 8,476,496 2021-09-24 0

    BEIGENE, LTD.

    • 10% Owner
    		 7,348,437 2021-09-24 0

    HEALTHCARE VENTURES IX, L.P.

    HEALTHCARE PARTNERS IX, L.P.

    HEALTHCARE PARTNERS IX, LLC

    • 10% Owner
    		 No longer subject to file 2021-02-09 0

    HEALTHCARE VENTURES VIII, L.P.

    HEALTHCARE PARTNERS VIII, LLC

    HEALTHCARE PARTNERS VIII, L.P.

    • 10% Owner
    		 No longer subject to file 2020-12-28 0

    LITTLECHILD JOHN W

    • Director
    • 10% Owner
    		 0 2020-03-02 0

    LILLY ELI & CO

    • 10% Owner
    		 0 2018-07-30 0

    WERNER HAROLD R

    • 10% Owner
    		 0 2018-07-30 0

    HEALTHCARE VENTURES VIII, L.P.

    HEALTHCARE PARTNERS VIII, L.P.

    HEALTHCARE PARTNERS VIII, LLC

    WERNER HAROLD R

    • 10% Owner
    		 2,618,406 2017-01-20 0

    HEALTHCARE VENTURES IX, L.P.

    HEALTHCARE PARTNERS IX, LLC

    • 10% Owner
    		 2,515,607 2017-01-20 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    LOSCALZO JOSEPH - Director

    		2023-08-25 16:30:30 -0400 2023-08-23 A 15,000 a 15,000 direct

    DIETZ THOMAS JOHN - Director

    		2023-08-25 16:31:29 -0400 2023-08-23 A 17,500 a 17,500 direct

    LI WILLIAM - Director

    		2023-08-25 16:31:25 -0400 2023-08-23 A 15,000 a 15,000 direct

    MARTIN PATRICIA A. - Director

    		2023-08-25 16:31:20 -0400 2023-08-23 A 15,000 a 15,000 direct

    LAWLOR AUGUSTINE - Officer CHIEF OPERATING OFFICER

    		2023-08-25 16:31:15 -0400 2023-08-23 A 70,000 a 70,000 direct

    MASHIACH NISSIM - Director

    		2023-08-25 16:31:10 -0400 2023-08-23 A 15,000 a 15,000 direct

    RICHARD CHRISTIAN M - Director

    		2023-08-25 16:31:06 -0400 2023-08-23 A 15,000 a 15,000 direct

    MIRABELLI CHRISTOPHER - Director - Officer CHAIRMAN OF THE BOARD

    		2023-08-25 16:31:01 -0400 2023-08-23 A 70,000 a 70,000 direct

    ONSI DOUGLAS E - Director - Officer CEO,CFO,PRES.,GC,TREAS.,&SEC.

    		2023-08-25 16:30:56 -0400 2023-08-23 A 140,000 a 140,000 direct

    SCHILSKY RICHARD - Director

    		2023-08-25 16:30:52 -0400 2023-08-23 A 15,000 a 15,000 direct

    CAVANAUGH JAMES H - Director

    		2023-08-25 16:30:47 -0400 2023-08-23 A 15,000 a 15,000 direct

    GRANFIELD CHRISTINE - Officer VP, HEAD OF REG AFFAIRS/QUAL

    		2023-08-25 16:30:42 -0400 2023-08-23 A 70,000 a 70,000 direct

    O'MAHONY JOHN MARK - Officer CHIEF MANUFACTURING OFFICER

    		2023-08-25 16:30:37 -0400 2023-08-23 A 70,000 a 70,000 direct

    BAUM JASON - Officer CHIEF SCIENTIFIC OFFICER

    		2023-08-25 16:30:34 -0400 2023-08-23 A 70,000 a 70,000 direct

    SIRARD CYNTHIA - Officer CHIEF MEDICAL OFFICER

    		2023-08-25 16:30:33 -0400 2023-08-23 A 70,000 a 70,000 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    LEAP THERAPEUTICS INC LPTX 2023-09-22 22:15:03 UTC -3.574 8.894 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 21:45:04 UTC -3.574 8.894 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 21:15:04 UTC -3.574 8.894 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 20:45:04 UTC -3.574 8.894 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 20:15:04 UTC -3.574 8.894 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 19:45:03 UTC -3.574 8.894 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 19:15:04 UTC -3.574 8.894 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 18:45:03 UTC -3.574 8.894 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 18:15:04 UTC -3.574 8.894 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 17:45:04 UTC 0.0 0.0 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 17:15:04 UTC 0.0 0.0 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 16:45:03 UTC 0.0 0.0 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 16:15:04 UTC 0.0 0.0 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 15:45:04 UTC -3.574 8.894 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 15:15:04 UTC -3.574 8.894 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 14:45:03 UTC -3.574 8.894 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 14:15:04 UTC -3.574 8.894 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 13:45:03 UTC -1.893 7.213 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 13:15:04 UTC -1.893 7.213 300000
    LEAP THERAPEUTICS INC LPTX 2023-09-22 12:45:04 UTC -1.893 7.213 300000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments